Accelerate Diagnostics is an in vitro diagnostics company. The company's Accelerate Pheno? system utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial and fungal cells are resistant or susceptible to a particular antimicrobial. The Accelerate PhenoTest? BC Kit, which is the test kit for the system, provides ID and AST results for patients suspected of bacteremia or fungemia, both conditions with morbidity and mortality risk. The Accelerate Pheno? system comprises of a robotic pipettor for fluidic manipulation, an optical system, and an imaging system.

Bryn Mawr Bank is a bank holding company. Through its subsidiary, The Bryn Mawr Trust Company (the Bank), the company provides a range of personal and business banking services, consumer and commercial loans, equipment leasing, mortgages, insurance and wealth management services, including investment management, trust and estate administration, retirement planning, custody services, and tax planning and preparation. The Bank is engaged in commercial and retail banking business, providing basic banking services, including the acceptance of demand, time and savings deposits and the origination of commercial, real estate and consumer loans and other extensions of credit including leases.

Century Bancorp is a bank holding company. Through its subsidiary, Century Bank and Trust Company, the company provides services to commercial enterprises, state and local governments and agencies, non-profit organizations and individuals. The company also provides securities brokerage services through a program called Investment Services at Century Bank, which is supported by LPL Financial, a third party securities brokerage business. The company grants single-family and multi-family residential loans, commercial and commercial real estate loans, municipal loans, and a variety of consumer loans. In addition, the company provides savings accounts, NOW accounts, demand deposits, time deposits and money market accounts.

Evercore is a holding company. Through its subsidiaries, the company is an investment banking advisory firm. The company's segments include: Investment Banking, which includes the advisory business through which it provides advice to clients on mergers, acquisitions, divestitures, shareholder activism and other corporate transactions, and the Evercore International Strategy and Investment business through which it provides macroeconomic, policy and fundamental equity research and agency-based equity securities trading for institutional investors; and Investment Management, which includes the wealth management business through which it provides investment advisory, wealth management and fiduciary services.

Integra LifeSciences Holdings is a medical devices company engaged in the development, manufacturing, and marketing of surgical implants and medical instruments. The company manufactures and sells its products in the following two reportable business segments: Codman Specialty Surgical, which includes technologies in dural repair, ultrasonic tissue ablation, intracranial cranial pressure monitoring, hydrocephalus management, and cranial stabilization systems; and Orthopedics and Tissue Technologies, which focus on addressing soft tissue, nerve, and tendon repairs as well as reconstruction in the hand, wrist, elbow, shoulder, ankle and foot.

Rubius Therapeutics is a therapeutics company focused on using its platform to develop red cell therapeutics for the treatment of patients with severe diseases. The company is developing a class of cellular medicines, called Red Cell Therapeutics? for patients with cancer and autoimmune diseases based on two therapeutic modalities - potent cell-cell interaction and tolerance induction. The company's product candidates pipeline comprised of: RTX-240 for the treatment of solid tumors; RTX-240 for the treatment of acute myeliod leukemia; RTX-321 artificial antigen presenting cell program for the treatment of solid tumors; RTX-224 for the treatment of solid tumors; and RTX-T1D for the treatment of diabetes.

SunPower is a holding company. Through its subsidiaries, the company is an energy company that delivers solar solutions to residential, commercial, and power plant customers worldwide. The company has two segments: SunPower Energy Services, which refers to sales of solar energy solutions in the North America including direct sales of turn-key engineering, procurement and construction services, and sales to resellers, among other; and SunPower Technologies, which refers to its technology development, worldwide solar panel manufacturing operations, equipment supply to resellers, commercial and residential end-customers outside of North America, and worldwide power plant project development and project sales.

Synnex is a business process services company, providing a range of distribution, logistics and integration services for the technology industry and providing outsourced services focused on customer engagement to a range of enterprises. The company's segments are: Technology Solutions, which distributes peripherals, information technologysystems including data center server and storage solutions, system components, software, networking, communications and security equipment; and Concentrix, which provides a portfolio of solutions and business services focused on customer engagement, process optimization, technology innovation, front and back-office automation and business transformation to clients.